Myojin M, Horimoto Y, Ito M, Kitano S, et al. Neutrophil-to-lymphocyte ratio and histological type might predict clinical
responses to eriburin-based treatment in patients with metastatic breast cancer. Breast Cancer 2020 Feb 27. pii: 10.1007/s12282-020-01069.
PMID: 32108306